Table V.
Multivariate analysis for overall survival in patients with adjuvant gemcitabine.
| Factors | HR (95% CI) | p-value |
|---|---|---|
| Age | 0.002 | |
| <65 | 1.0 | |
| ≥65 | 0.227 (0.089–0.580) | |
| Tumor size (cm) | 0.280 | |
| <4 | 1.0 | |
| ≥4 | 0.593 (0.230–1.531) | |
| Histology | 0.267 | |
| Well/Mod | 1.0 | |
| Poor | 1.907 (0.610–5.964) | |
| M | 0.923 | |
| M0 | 1.0 | |
| M1 | 0.947 (0.315–2.847) | |
| Curability of surgery | 0.784 | |
| R0 | 1.0 | |
| R1 | 1.145 (0.433–3.029) | |
| BRM | 0.017 | |
| Low | 1.0 | |
| High | 3.411 (1.251–9.305) | |
| BAF180 | 0.016 | |
| Low | 1.0 | |
| High | 0.336 (0.138–0.819) |
HR, hazard ratio; 95% CI, 95% confidence interval; well, well differentiated adenocarcinoma; mod, moderately differentiated adenocarcinoma; poor, poorly differentiated adenocarcinoma.